Impact of Primary Letermovir Prophylaxis Versus Preemptive Antiviral Therapy for Cytomegalovirus on Economic and Clinical Outcomes after Hematopoietic Cell Transplantation is a research paper published in Transplantation and Cellular Therapy (2024). On theSindex it has a DataRank of 0.548. It has been cited 12 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.164
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
NIH
Grant: P01 CA23766
NCI NIH HHS
Grant: P01 CA023766
NCI NIH HHS
Grant: P30 CA008748
Meso Scale Diagnostics
Merck Sharp & Dohme Ltd
Takeda Pharmaceuticals U.S.A.
MeSH Terms
Keywords